AbbVie Inc.
ABBV | NYSE
$266.14
+$1.66 (+0.63%)
Sep 22, 2026, 12:43 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 96.41 | 74.04 | 56.77 | 24.30 | 20.90 | 39.25 |
PEG Ratio | -77.13 | -6.13 | -0.96 | 9.26 | 0.15 | -0.81 |
PS Ratio | 6.63 | 5.58 | 5.04 | 4.93 | 4.26 | 3.90 |
PB Ratio | -123.96 | 94.54 | 26.45 | 16.59 | 15.55 | 13.66 |
P/FCF Ratio | 22.75 | 17.63 | 12.42 | 11.80 | 10.90 | 10.64 |
P/OCF Ratio | 21.30 | 16.72 | 12 | 11.47 | 10.52 | 10.16 |
OCF/S Ratio | 31.12 | 33.38 | 42.05 | 42.97 | 40.53 | 38.40 |
Debt / Equity Ratio | -21.12 | 20.40 | 5.80 | 3.72 | 5.03 | 6.66 |
Quick Ratio | 0.56 | 0.55 | 0.76 | 0.84 | 0.70 | 0.73 |
Current Ratio | 0.67 | 0.66 | 0.87 | 0.96 | 0.79 | 0.84 |
Asset Turnover | 0.46 | 0.42 | 0.40 | 0.42 | 0.38 | 0.30 |
Interest Coverage | 6.94 | 3.25 | 5.74 | 8.12 | 7.40 | 4.63 |
Return on Equity | -129.24% | 128.66% | 46.94% | 68.60% | 74.91% | 35.30% |
Return on Assets | 3.15% | 3.17% | 3.61% | 8.53% | 7.88% | 3.07% |
Return on Invested Capital | 12.97% | 8.85% | 9.56% | 14.02% | 12.85% | 8.70% |
Dividend Yield | 2.88% | 3.51% | 3.85% | 3.51% | 3.86% | 4.32% |
Payout Ratio | 275.84% | 257.71% | 216.72% | 84.85% | 80.24% | 167.16% |
FCF Payout Ratio | 69.14% | 65.16% | 49.44% | 42.60% | 43.48% | 48.11% |
Gross Profit Margin | 70.24% | 69.99% | 62.42% | 70% | 68.96% | 66.41% |
Net Profit Margin | 6.91% | 7.59% | 8.95% | 20.39% | 20.54% | 10.08% |
Pretax Profit Margin | 10.79% | 6.60% | 11.51% | 23.21% | 23.11% | 7.42% |
Operating Profit Margin | 32.85% | 16.22% | 23.49% | 31.21% | 31.89% | 24.81% |
FCF Margin | 29.13% | 31.65% | 40.62% | 41.77% | 39.13% | 36.66% |
EBITDA Margin | 28.82% | 26.47% | 31.61% | 41.64% | 42.59% | 26.90% |
Add to Watchlist
Select watchlists to add or remove ABBV